House Committee Chairs Maloney, Clyburn Reveal That Quality Failures by Emergent BioSolutions Rendered 135 Million Additional Coronavirus Vaccine Doses Unusable
August 12, 2022
August 12, 2022
WASHINGTON, Aug. 12 -- Rep. Carolyn Maloney, D-New York, chair of the House Oversight and Reform Committee, issued the following news release:
Rep. Carolyn B. Maloney, Chairwoman of the Committee on Oversight and Reform, and Rep. James E. Clyburn, Chairman of the Select Subcommittee on the Coronavirus Crisis, released new evidence that 135 million coronavirus vaccine doses manufactured at Emergent BioSolutions' (Emergent) Bayview facility in Baltimore, Maryland between August 2 . . .
Rep. Carolyn B. Maloney, Chairwoman of the Committee on Oversight and Reform, and Rep. James E. Clyburn, Chairman of the Select Subcommittee on the Coronavirus Crisis, released new evidence that 135 million coronavirus vaccine doses manufactured at Emergent BioSolutions' (Emergent) Bayview facility in Baltimore, Maryland between August 2 . . .